Found: 14
Select item for more details and to access through your institution.
Identification of Diverse Microbial Metabolites as Potent Inhibitors of HIV-1 Tat Transactivation.
- Published in:
- Chemistry & Biodiversity, 2005, v. 2, n. 1, p. 112, doi. 10.1002/cbdv.200490162
- By:
- Publication type:
- Article
Limitations of real-world treatment with atorvastatin monotherapy for lowering LDL-C in high-risk cardiovascular patients in the US.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Limitations of real-world treatment with atorvastatin monotherapy for lowering LDL-C in high-risk cardiovascular patients in the US.
- Published in:
- Vascular Health & Risk Management, 2014, v. 10, p. 237, doi. 10.2147/VHRM.S54886
- By:
- Publication type:
- Article
Changes in LDL-Clevels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy.
- Published in:
- Vascular Health & Risk Management, 2013, v. 9, p. 719, doi. 10.2147/vhrm.s49840
- By:
- Publication type:
- Article
Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Three-month antibody persistence of a bivalent Omicron-containing booster vaccine against COVID-19.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-38892-w
- By:
- Publication type:
- Article
Patient and physician factors influence decision-making in hypercholesterolemia: a questionnaire-based survey.
- Published in:
- Lipids in Health & Disease, 2015, v. 14, n. 1, p. 1, doi. 10.1186/s12944-015-0037-y
- By:
- Publication type:
- Article
Effect of Switching From Statin Monotherapy to Ezetimibe/Simvastatin Combination Therapy Compared With Other Intensified Lipid-Lowering Strategies on Lipoprotein Subclasses in Diabetic Patients With Symptomatic Cardiovascular Disease.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Associations of Immunogenicity and Reactogenicity After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA-1273 Vaccine in the COVE and TeenCOVE Trials.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 2, p. 271, doi. 10.1093/cid/ciac780
- By:
- Publication type:
- Article
Fixed-dose combination ezetimibe+atorvastatin lowers LDL-C equivalent to co-administered components in randomized trials: use of a dose-response model.
- Published in:
- Fundamental & Clinical Pharmacology, 2015, v. 29, n. 2, p. 209, doi. 10.1111/fcp.12096
- By:
- Publication type:
- Article
Long-term safety and effectiveness of mRNA-1273 vaccine in adults: COVE trial open-label and booster phases.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-50376-z
- By:
- Publication type:
- Article
Interim Report of the Reactogenicity and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 XBB–Containing Vaccines.
- Published in:
- Journal of Infectious Diseases, 2024, v. 230, n. 2, p. e279, doi. 10.1093/infdis/jiae067
- By:
- Publication type:
- Article
Effect of Extended-Release Niacin on New-Onset Diabetes Among Hyperlipidemic Patients Treated With Ezetimibe/Simvastatin in a Randomized Controlled Trial.
- Published in:
- Diabetes Care, 2012, v. 35, n. 4, p. 857, doi. 10.2337/dc11-1369
- By:
- Publication type:
- Article
Relationships Between Metabolic Syndrome and Other Baseline Factors and the Efficacy of Ezetimibe/Simvastatin and Atorvastatin in Patients With Type 2 Diabetes and Hypercholesterolemia.
- Published in:
- Diabetes Care, 2010, v. 33, n. 5, p. 1021, doi. 10.2337/dc09-1762
- By:
- Publication type:
- Article